[对乙型病毒性肝炎（HBV）病原体疫苗接种在高危人群中的反应]
[Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk].
作者信息
Lavezzi M, Donati A, Davi D, Carpanelli M C, Farinelli S, Soracco E
机构信息
Laboratorio di analisi chimico-cliniche e microbiologiche, U.S.L. 32 Emilia Romagna, Portomaggiore, Ferrara.
出版信息
Quad Sclavo Diagn. 1987 Jun;23(2):164-8.
PMID:2967519
Abstract
We report the results of the vaccinations against hepatitis B carried out with vaccine H-B-VAX of the commercial firm (Merck Sharp and Dohme), on 102 U.S.L. 32 hospital workers in Portomaggiore (Ferrara, Italy). The vaccine rendered 92% of the subjects inoculated immune and the incidence of secondary effects was low.
摘要
我们报告了使用商业公司（默克雪兰诺）的H-B-VAX疫苗对意大利费拉拉省波托马焦雷市32号医院的102名医护人员进行乙型肝炎疫苗接种的结果。该疫苗使92%的接种者产生了免疫力，且副作用发生率较低。
Zotero 插件